251 related articles for article (PubMed ID: 21737767)
1. Bupropion and restless legs syndrome: a randomized controlled trial.
Bayard M; Bailey B; Acharya D; Ambreen F; Duggal S; Kaur T; Rahman ZU; Roller K; Tudiver F
J Am Board Fam Med; 2011; 24(4):422-8. PubMed ID: 21737767
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy of ropinirole for restless legs syndrome is not affected by age at symptom onset.
Allen RP; Ritchie SY
Sleep Med; 2008 Dec; 9(8):899-902. PubMed ID: 18024167
[TBL] [Abstract][Full Text] [Related]
3. Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome.
Bliwise DL; Freeman A; Ingram CD; Rye DB; Chakravorty S; Watts RL
Sleep Med; 2005 Mar; 6(2):141-7. PubMed ID: 15716217
[TBL] [Abstract][Full Text] [Related]
4. Does valerian improve sleepiness and symptom severity in people with restless legs syndrome?
Cuellar NG; Ratcliffe SJ
Altern Ther Health Med; 2009; 15(2):22-8. PubMed ID: 19284179
[TBL] [Abstract][Full Text] [Related]
5. Ropinirole in patients with restless legs syndrome and baseline IRLS total scores ≥ 24: efficacy and tolerability in a 26-week, double-blind, parallel-group, placebo-controlled study followed by a 40-week open-label extension.
Giorgi L; Asgharian A; Hunter B
Clin Ther; 2013 Sep; 35(9):1321-36. PubMed ID: 23938061
[TBL] [Abstract][Full Text] [Related]
6. Effect of pramipexole on RLS symptoms and sleep: a randomized, double-blind, placebo-controlled trial.
Ferini-Strambi L; Aarskog D; Partinen M; Chaudhuri KR; Sohr M; Verri D; Albrecht S
Sleep Med; 2008 Dec; 9(8):874-81. PubMed ID: 18952497
[TBL] [Abstract][Full Text] [Related]
7. Patient- and physician-rated measures demonstrate the effectiveness of ropinirole in the treatment of restless legs syndrome.
Kushida CA; Geyer J; Tolson JM; Asgharian A
Clin Neuropharmacol; 2008; 31(5):281-6. PubMed ID: 18836346
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of ropinirole in patients with restless legs syndrome and a baseline IRLS total score > or = 24 points--data from the ropinirole clinical trial programme.
Giorgi L; Ritchie SY; Kirsch JM
Curr Med Res Opin; 2006 Oct; 22(10):1867-77. PubMed ID: 17022844
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of cabergoline in restless legs syndrome: a placebo-controlled study with polysomnography (CATOR).
Oertel WH; Benes H; Bodenschatz R; Peglau I; Warmuth R; Happe S; Geisler P; Cassel W; Leroux M; Kohnen R; Stiasny-Kolster K
Neurology; 2006 Sep; 67(6):1040-6. PubMed ID: 16931508
[TBL] [Abstract][Full Text] [Related]
10. Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies.
Fulda S; Wetter TC
Brain; 2008 Apr; 131(Pt 4):902-17. PubMed ID: 17932100
[TBL] [Abstract][Full Text] [Related]
11. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study.
Walters AS; Ondo WG; Dreykluft T; Grunstein R; Lee D; Sethi K;
Mov Disord; 2004 Dec; 19(12):1414-23. PubMed ID: 15390050
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of vitamins C, E, and their combination for treatment of restless legs syndrome in hemodialysis patients: a randomized, double-blind, placebo-controlled trial.
Sagheb MM; Dormanesh B; Fallahzadeh MK; Akbari H; Sohrabi Nazari S; Heydari ST; Behzadi S
Sleep Med; 2012 May; 13(5):542-5. PubMed ID: 22317944
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of pramipexole in Japanese patients with primary restless legs syndrome: A polysomnographic randomized, double-blind, placebo-controlled study.
Inoue Y; Hirata K; Kuroda K; Fujita M; Shimizu T; Emura N; Uchimura N; Kagimura T; Sha K; Nozawa T
Sleep Med; 2010 Jan; 11(1):11-6. PubMed ID: 19962941
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of oral iron in patients with restless legs syndrome and a low-normal ferritin: A randomized, double-blind, placebo-controlled study.
Wang J; O'Reilly B; Venkataraman R; Mysliwiec V; Mysliwiec A
Sleep Med; 2009 Oct; 10(9):973-5. PubMed ID: 19230757
[TBL] [Abstract][Full Text] [Related]
16. Restless legs syndrome in end-stage renal disease.
Gigli GL; Adorati M; Dolso P; Piani A; Valente M; Brotini S; Budai R
Sleep Med; 2004 May; 5(3):309-15. PubMed ID: 15165541
[TBL] [Abstract][Full Text] [Related]
17. Randomized, double-blind, placebo-controlled study of XP13512/GSK1838262 in patients with RLS.
Kushida CA; Becker PM; Ellenbogen AL; Canafax DM; Barrett RW;
Neurology; 2009 Feb; 72(5):439-46. PubMed ID: 19188575
[TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial.
Allen RP; Adler CH; Du W; Butcher A; Bregman DB; Earley CJ
Sleep Med; 2011 Oct; 12(9):906-13. PubMed ID: 21978726
[TBL] [Abstract][Full Text] [Related]
19. Restless legs syndrome: clinical experience with long-term treatment.
Clavadetscher SC; Gugger M; Bassetti CL
Sleep Med; 2004 Sep; 5(5):495-500. PubMed ID: 15341896
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of sumanirole in restless legs syndrome: a phase II, randomized, double-blind, placebo-controlled, dose-response study.
Garcia-Borreguero D; Winkelman J; Adams A; Ellis A; Morris M; Lamb J; Layton G; Versavel M;
Sleep Med; 2007 Mar; 8(2):119-27. PubMed ID: 17239657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]